Victrex plc (LON:VCT – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 993.36 ($12.40) and traded as high as GBX 1,016 ($12.69). Victrex shares last traded at GBX 996 ($12.44), with a volume of 121,620 shares traded.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank dropped their price target on Victrex from GBX 1,290 ($16.11) to GBX 1,170 ($14.61) and set a “hold” rating on the stock in a research report on Wednesday, December 4th.
Get Our Latest Stock Analysis on VCT
Victrex Stock Performance
Victrex (LON:VCT – Get Free Report) last posted its quarterly earnings data on Tuesday, December 24th. The company reported GBX 51.70 ($0.65) earnings per share (EPS) for the quarter. Victrex had a return on equity of 6.36% and a net margin of 10.81%. On average, research analysts anticipate that Victrex plc will post 73.1078905 EPS for the current year.
Victrex Increases Dividend
The company also recently disclosed a dividend, which will be paid on Friday, February 21st. Investors of record on Thursday, January 23rd will be issued a dividend of GBX 46.14 ($0.58) per share. The ex-dividend date of this dividend is Thursday, January 23rd. This is an increase from Victrex’s previous dividend of $13.42. This represents a dividend yield of 5.26%. Victrex’s dividend payout ratio (DPR) is presently 17,142.86%.
Insider Buying and Selling
In related news, insider Brendan Connolly purchased 980 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was purchased at an average cost of GBX 1,019 ($12.72) per share, for a total transaction of £9,986.20 ($12,468.72). Also, insider Ian Melling purchased 2,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was bought at an average price of GBX 1,135 ($14.17) per share, with a total value of £22,700 ($28,343.11). 1.64% of the stock is owned by corporate insiders.
Victrex Company Profile
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Further Reading
- Five stocks we like better than Victrex
- What is the MACD Indicator and How to Use it in Your Trading
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Manufacturing Stocks Investing
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Find Undervalued Stocks
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.